<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230314057713N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-04-07</date_registration>
      <primary_sponsor>Babol University of Medical Sciences</primary_sponsor>
      <public_title>The effect of cassia fistula product</public_title>
      <acronym></acronym>
      <scientific_title>The comparison of effect of the topical product of Cassia fistula on diaper rash of infants in comparison with hydrocortisone: a double-blind clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>138</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/69153</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be done using the method of random permutation blocks. The size of the blocks is 4 and the ratio of drug to control (hydrocortisone ointment) in each group is equal (1:1).
In each block, random permutations of 4 combinations of Flos and hydrocortisone formulations are considered, Blinding description: Cassia fistula product ointment and hydrocortisone will be packed and coded in a single form with the same consistency and color and smell (with the addition of color and essential oil) with the same label by a pharmaceutical specialist in the medicinal plant laboratory of the Iranian Medicine School of Babol. The only person who knows the nature of the drugs is the pharmacist who manufactures the drug. Random codes are written on the boxes containing the drug (floss/hydrocortisone product) and after assigning the drug to the patients, the relevant code is recorded on the patient's file. to be The opening of the codes will be done after the end of the study.</study_design>
      <phase>3</phase>
      <hc_freetext>Inflammation of the diaper area.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The evaluation of people entering the study is done by a doctor specializing in children and infants, and in case of clinical suspicion that there is a severe disease and severe bacterial and fungal infections that have led to local inflammation (severe type or a score higher than 3 ) is removed from the study and is subjected to standard treatment. Every person who meets the criteria for entering the study is evaluated by an Iranian medical expert using the Ddsis tool (diaper dermatitis severity index score) in the first and subsequent visits and with this tool The score of the patient is determined. According to the summary of studies, the average recovery period is 7 days. The patients were followed up every day according to the assistant's phone call with the mother and based on the changes with the initial examination, and according to the in-person examination by the assistant on the first, fourth and seventh days, the changes in the score index were measured at the beginning and then at the end of the treatment, and statistically, between Two groups are compared. The duration of treatment is also evaluated. Intervention 2: Control group: The evaluation of people entering the study is done by a doctor specializing in children and infants, and in case of clinical suspicion that there is a severe disease and severe bacterial and fungal infections that have led to local inflammation (severe type or a score higher than 3 ) is removed from the study and is subjected to standard treatment. Every person who meets the criteria for entering the study is evaluated by an Iranian medical expert using the Ddsis tool (diaper dermatitis severity index score) in the first and subsequent visits and with this tool The score of the patient is determined. According to the summary of studies, the average recovery period is 7 days. The patients were followed up every day according to the assistant's phone call with the mother and based on the changes with the initial examination, and according to the in-person examination by the assistant on the first, fourth and seventh days, the changes in the score index were measured at the beginning and then at the end of the treatment, and statistically, between Two groups are compared. The duration of treatment is also evaluated.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Ali Muzaffarpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, University Square, Ganj Afrooz St</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>47176-47745</zip>
        <telephone>+98 11 3219 9592</telephone>
        <email>Seyyedali1357@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Ali Muzaffarpour</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Babol University of Medical Sciences, University Square, Ganj Afrooz Street</address>
        <city>Babol</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>47176-47745</zip>
        <telephone>+98 11 3219 9592</telephone>
        <email>Seyyedali1357@gmail.com</email>
        <affiliation>Babol University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Infants under two years old age
Inflammation of diaper area</inclusion_criteria>
      <agemin>1 day</agemin>
      <agemax>2 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Atopic dermatitis and other skin dermatitis
Other diaper rash treatment from 2 weeks ago
Sever type or inflammation with above score 3
Drug sensivity
Diarrhea
Oral antibiotic consumption</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The evaluation of people entering the study is done by a doctor specializing in children and infants, and in case of clinical suspicion that there is a severe disease and severe bacterial and fungal infections that have led to local inflammation (severe type or a score higher than 3 ) is removed from the study and is subjected to standard treatment. Every person who meets the criteria for entering the study is evaluated by an Iranian medical expert using the Ddsis tool (diaper dermatitis severity index score) in the first and subsequent visits and with this tool The score of the patient is determined. According to the summary of studies, the average recovery period is 7 days. The patients were followed up every day according to the assistant's phone call with the mother and based on the changes with the initial examination, and according to the in-person examination by the assistant on the first, fourth and seventh days, the changes in the score index were measured at the beginning and then at the end of the treatment, and statistically, between Two groups are compared. The duration of treatment is also evaluated</i_keyword>
      <i_keyword>Control group: The evaluation of people entering the study is done by a doctor specializing in children and infants, and in case of clinical suspicion that there is a severe disease and severe bacterial and fungal infections that have led to local inflammation (severe type or a score higher than 3 ) is removed from the study and is subjected to standard treatment. Every person who meets the criteria for entering the study is evaluated by an Iranian medical expert using the Ddsis tool (diaper dermatitis severity index score) in the first and subsequent visits and with this tool The score of the patient is determined. According to the summary of studies, the average recovery period is 7 days. The patients were followed up every day according to the assistant's phone call with the mother and based on the changes with the initial examination, and according to the in-person examination by the assistant on the first, fourth and seventh days, the changes in the score index were measured at the beginning and then at the end of the treatment, and statistically, between Two groups are compared. The duration of treatment is also evaluated</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Duration of treatment. Timepoint: each day. Method of measurement: Counting days.</prim_outcome>
      <prim_outcome>Intensity of redness. Timepoint: Counting days. Method of measurement: diaper dermatitis severity index score.</prim_outcome>
      <prim_outcome>The extent of redness. Timepoint: Counting days. Method of measurement: Percentage of diaper area.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Babol University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-03-12</approval_date>
        <contact_name>Ethics Committee of Babol University of Medical Sciences</contact_name>
        <contact_address>Keshavarz Street, University Square, Babol University of Medical Sciences Babol Mazandaran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
